Acucela is tasked with pushing adenosine A2a receptor agonist into the clinic. Acucela and Otsuka Pharmaceutical will work together to develop the latter’s candidate for glaucoma treatment called ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results